Del-Budai Centrumkorhaz Szent Imre Egyetemi Oktatokorhaz

The centre is investigating novel strategies to improve cardiovascular risk management, focusing on blood‑pressure control and cholesterol reduction for patients with elevated heart‑related danger.

• Hyperlipidaemia
• Resistant hypertension
• Uncontrolled hypertension
• Acute heart failure

With 11 dedicated investigators, the site supports 14 active studies and contributes to Hungary’s growing clinical‑research landscape from its Budapest location.

Researchers are assessing the long‑term safety and therapeutic benefit of emerging agents for patients with severe intestinal insufficiency, aiming to enhance nutrition absorption and quality of life.

• Short Bowel Syndrome
• Venous thromboembolism in gastrointestinal cancer

The Endocrinology and Metabolic Centre collaborates with local hospitals to enroll participants and generate data that may reshape treatment standards for complex digestive conditions.

The department is testing a targeted immunomodulator to reduce inflammation and maintain remission in a rare vasculitis, offering hope for patients who face vision loss and severe pain.

• Giant Cell Arteritis

This work reflects the site’s commitment to advancing therapies for autoimmune disorders through rigorous safety and efficacy evaluation.

Ongoing trials evaluate cutting‑edge biologics and antibody‑drug conjugates designed to halt tumor growth and prolong survival in several aggressive cancers.

• HER2‑positive metastatic breast cancer
• Hormone‑receptor‑positive HER2‑negative advanced breast cancer
• Resectable cutaneous squamous cell carcinoma
• General breast cancer

By integrating immunotherapy and targeted agents, the site seeks to expand therapeutic options for patients confronting life‑threatening tumors.

A combination regimen is being examined for its ability to alleviate painful symptoms and improve nerve function in individuals with diabetes‑related nerve damage.

• Diabetic sensorimotor polyneuropathy

The study underscores the centre’s focus on neuro‑metabolic complications that significantly impact daily living.

Clinical investigations target metabolic imbalances, aiming to lower harmful lipids and support patients with chronic nutrient‑absorption challenges.

• Hyperlipidaemia
• Metabolic complications of short bowel syndrome

Through these trials, the Budapest facility contributes valuable insights into managing disorders that affect the body’s energy and nutrient pathways.